It has been more than one year since the first case of the coronaviruses was infected by
COVID-19 in China. The world witnessed three waves of the corona virus till now, and more …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19), which has spread worldwide since it was first …

Abstract The SARS-CoV-2 Omicron subvariant BA. 5 rapidly spread worldwide and replaced
BA. 1/BA. 2 in many countries, becoming globally dominant. BA. 5 has unique amino acid …

Vaccine-associated enhanced respiratory disease (VAERD) is a severe complication for
some respiratory infections. To investigate the potential for VAERD induction in coronavirus …

Abstract ChAdOx1 nCoV-19 (AZD1222) is a replication-deficient simian adenovirus–
vectored vaccine encoding the spike (S) protein of SARS-CoV-2, based on the first …

Current COVID-19 vaccines are based on prototypic spike sequences from ancestral 2019
SARS-CoV-2 strains. However, the ongoing pandemic is fueled by variants of concern …

The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a
threat to the efficacy of current COVID-19 vaccines,. The Ad26. COV2. S vaccine expresses …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern have
emerged and may pose a threat to both the efficacy of vaccines based on the original …

Two doses of the MVA-CoV2-S vaccine candidate expressing the SARS-CoV-2 spike (S)
protein protected K18-hACE2 transgenic mice from a lethal dose of SARS-CoV-2. This …

Despite mass public health efforts, the SARS-CoV2 pandemic continues as of late 2021 with
resurgent case numbers in many parts of the world. The emergence of SARS-CoV2 variants …